About the article
Soultana Markopoulou received her BSc (Hons) in Genetics from the University of Liverpool, her MSc in Biotechnology from Liverpool John-Moores University and her PhD in Molecular Physiology from the University of Ioannina Medical School. Her postdoctoral training included a fellowship at the Biomarkers Group at the Liverpool CR-UK Centre where she focused on developing quantitative real-time PCR-based methods to measure abnormal DNA methylation in sputum specimens. Her main research interests are in molecular oncology and its translational potential.
Georgios Nikolaidis studied Biochemistry (BSc Hons) at Coventry University and received his MSc in Industrial Biotechnology from Liverpool John Moores University. He worked as research technician in the Liverpool Lung Project as a member of the Biomarkers Group. He has subsequently undertaken his PhD at the University of Liverpool in the area of epigenetics. His research focuses on DNA methylation biomarker development for early lung cancer detection.
Triantafillos Liloglou received his BSc (Hons) in Biology from the Aristotelian University of Thessaloniki and his PhD in molecular oncology from the University of Crete Medical School. After his post-doctoral training at the University of Liverpool he became a group leader at the time he joined the Liverpool Lung Project in 1998. His research interests are in genetic and epigenetic instability in cancers of the respiratory tract. His research is largely focused on biomarker discovery and validation in order to assist clinical management of respiratory cancer; in particular early detection and therapeutic stratification. Dr. Liloglou is currently a lecturer at the University of Liverpool, Department of Molecular & Clinical Cancer Medicine and a Biomarkers Group leader at the Liverpool CR-UK Centre.
Published Online: 2012-07-12
Published in Print: 2012-10-01